Spartan Planning & Wealth Management Gilead Sciences, Inc. Transaction History
Spartan Planning & Wealth Management
- $112 Million
- Q2 2025
A detailed history of Spartan Planning & Wealth Management transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Spartan Planning & Wealth Management holds 2,215 shares of GILD stock, worth $244,270. This represents 0.22% of its overall portfolio holdings.
Number of Shares
2,215
Previous 2,145
3.26%
Holding current value
$244,270
Previous $240,000
2.08%
% of portfolio
0.22%
Previous 0.24%
Shares
7 transactions
Others Institutions Holding GILD
# of Institutions
2,294Shares Held
1BCall Options Held
9.56MPut Options Held
9.96M-
Black Rock Inc. New York, NY121MShares$13.3 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$13 Billion0.25% of portfolio
-
State Street Corp Boston, MA59.5MShares$6.56 Billion0.28% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$6.02 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$5.91 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $138B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...